SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-010083
Filing Date
2022-04-15
Accepted
2022-04-15 16:11:03
Documents
13
Period of Report
2022-04-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43687
2 ex10-1.htm EX-10.1 78531
  Complete submission text file 0001493152-22-010083.txt   310718

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pulm-20220414.xsd EX-101.SCH 3036
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pulm-20220414_lab.xml EX-101.LAB 34476
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pulm-20220414_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3603
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 22830158
SIC: 2834 Pharmaceutical Preparations